Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.038 | 0.7 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |